Developing therapeutic approaches for metachromatic leukodystrophy

References

• Austin J McAfee D Armstrong D O’Rourke M Shearer L Bachhawat B Low sulfatase activities in metachromatic leukodystrophy (MLD). A controlled study of enzymes in 9 living and 4 autopsied patients with MLD Trans Am Neurol Assoc 1964 89 147 150 5828490
   PubMedGoogle Scholar
• Bosio A Binczek E Stoffel W Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis Proc Natl Acad Sci U S A 1996 12 93 23 13280 13285 8917582
   PubMed Web of Science ®Google Scholar
• Aggarwal S Yurlova L Simons M Central nervous system myelin: structure, synthesis and assembly Trends Cell Biol 2011 21 10 585 593 21763137
   PubMed Web of Science ®Google Scholar
• Faust PL Kaye EM Powers JM Myelin lesions associated with lysosomal and peroxisomal disorders Expert Rev Neurother 2010 10 9 1449 1466 20819015
   PubMed Web of Science ®Google Scholar
• Gieselmann V Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options Acta Paediatr Suppl 2008 97 457 15 21 18339182
   PubMedGoogle Scholar
• Mechtler TP Stary S Metz TF Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria Lancet 2012 379 9813 335 341 22133539
   PubMed Web of Science ®Google Scholar
• Meikle PJ Hopwood JJ Clague AE Carey WF Prevalence of lysosomal storage disorders. JAMA Jan 1999 281 3 249 254
   Google Scholar
• Von Figura K Metachromatic Leukodystrophy Scriver C Beaudet A Arthur L Sly WS Valle D Metabolic and Molecular Basis of Inherited Disease New York McGraw-Hill 2001 3 3696 3724
   Google Scholar
• Lugowska A Poninska J Krajewski P Broda G Ploski R Population carrier rates of pathogenic ARSA gene mutations: is metachromatic leukodystrophy underdiagnosed? PLoS One 2011 6 6 e20218 21695197
   PubMed Web of Science ®Google Scholar
• Stenson PD Ball EV Howells K Phillips AD Mort M Cooper DN The Human Gene Mutation Database: providing a comprehensive central mutation database for molecular diagnostics and personalized genomics Hum Genomics 2009 4 2 69 72 20038494
   PubMedGoogle Scholar
• Gieselmann V An assay for the rapid detection of the arylsulfatase A pseudodeficiency allele facilitates diagnosis and genetic counseling for metachromatic leukodystrophy Hum Genet 1991 86 3 251 255 1671769
   PubMed Web of Science ®Google Scholar
• Gieselmann V Polten A Kreysing J von Figura K Molecular genetics of metachromatic leukodystrophy J Inherit Metab Dis 1994 17 4 500 509 7967499
   PubMed Web of Science ®Google Scholar
• Gort L Coll MJ Chabas A Identification of 12 novel mutations and two new polymorphisms in the arylsulfatase A gene: haplotype and genotype-phenotype correlation studies in Spanish metachromatic leukodystrophy patients Hum Mutat 1999 14 3 240 248 10477432
   PubMed Web of Science ®Google Scholar
• Francis GS Bonni A Shen N Metachromatic leukodystrophy: multiple nonfunctional and pseudodeficiency alleles in a pedigree: problems with diagnosis and counseling Ann Neurol 1993 34 2 212 218 8101704
   PubMed Web of Science ®Google Scholar
• Hohenschutz C Eich P Friedl W Waheed A Conzelmann E Propping P Pseudodeficiency of arylsulfatase A: a common genetic polymorphism with possible disease implications Hum Genet 1989 82 1 45 48 2565866
   PubMed Web of Science ®Google Scholar
• Nelson PV Carey WF Morris CP Population frequency of the arylsulphatase A pseudo-deficiency allele Hum Genet 199 87 1 87 88
   Web of Science ®Google Scholar
• Ott R Waye JS Chang PL Evolutionary origins of two tightly linked mutations in arylsulfatase-A pseudodeficiency Hum Genet 1997 101 2 135 140 9402957
   PubMed Web of Science ®Google Scholar
• Sommerlade HJ Hille-Rehfeld A von Figura K Gieselmann V Four monoclonal antibodies inhibit the recognition of arylsulphatase A by the lysosomal enzyme phosphotransferase Biochem J 1994 297 Pt 1 123 130 7506530
   PubMed Web of Science ®Google Scholar
• Fluharty AL Fluharty CB Bohne W von Figura K Gieselmann V Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient Am J Hum Genet 1991 49 6 1340 1350 1684088
   PubMed Web of Science ®Google Scholar
• Harvey JS Nelson PV Carey WF Robertson EF Morris CP An arylsulfatase A (ARSA) missense mutation (T274M) causing late-infantile metachromatic leukodystrophy Hum Mutat 1993 2 4 261 267 8104633
   PubMed Web of Science ®Google Scholar
• Ghosh P Dahms NM Kornfeld S Mannose 6-phosphate receptors: new twists in the tale Nat Rev Mol Cell Biol 2003 4 3 202 212 12612639
   PubMed Web of Science ®Google Scholar
• Lukatela G Krauss N Theis K Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis Biochemistry 1998 37 11 3654 3664 9521684
   PubMed Web of Science ®Google Scholar
• Von Bulow R Schmidt B Dierks T Defective oligomerization of arylsulfatase a as a cause of its instability in lysosomes and metachromatic leukodystrophy J Biol Chem 2002 277 11 9455 9461 11777924
   PubMed Web of Science ®Google Scholar
• von Bulow R Schmidt B Dierks T von Figura K Uson I Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis J Mol Biol 2001 305 2 269 277 11124905
   PubMed Web of Science ®Google Scholar
• Siegel EG Lucke H Schauer W Creutzfeldt W Repeated upper gastrointestinal hemorrhage caused by metachromatic leukodystrophy of the gall bladder Digestion 1992 51 2 121 124 1499874
   PubMed Web of Science ®Google Scholar
• Ries M Deeg KH Polyposis of the gallbladder associated with metachromatic leukodystrophy Eur J Pediatr 1993 152 5 450 451 8319717
   PubMed Web of Science ®Google Scholar
• Kim TS Kim IO Kim WS Choi YS Yeon KM Hwang YS Involvement of the gallbladder in childhood metachromatic leukodystrophy: ultrasonographic findings J Ultrasound Med 1996 15 12 821 825 8947856
   PubMed Web of Science ®Google Scholar
• Oak S Rao S Karmarkar S Papillomatosis of the gallbladder in metachromatic leukodystrophy Pediatr Surg Int 1997 12 5–6 424 425 9244117
   PubMed Web of Science ®Google Scholar
• Simanovsky N Ackerman Z Kiderman A Fields S Unusual gallbladder findings in two brothers with metachromatic leukodystrophy Pediatr Radiol 1998 28 9 706 708 9732500
   PubMed Web of Science ®Google Scholar
• Krivan HC Olson LD Barile MF Ginsburg V Roberts DD Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate J Biol Chem 1989 264 16 9283 9288 2470753
   PubMed Web of Science ®Google Scholar
• Sugano K Tai T Kawashima I Localization of sulfatides in the epithelial lining of gastric mucosa: studies with a monoclonal antibody to sulfatides J Clin Gastroenterol 1995 21 Suppl 1 S98 S103 8774999
   PubMed Web of Science ®Google Scholar
• Takamatsu K Phytosphingosine-containing neutral glycosphingolipids and sulfatides in the human female genital tract: their association in the cervical epithelium and the uterine endometrium and their dissociation in the mucosa of fallopian tube with the menstrual cycle Keio J Med 1992 41 3 161 167 1434311
   PubMedGoogle Scholar
• Malone MJ Stoffyn P A comparative study of brain and kidney glycolipids in metachromatic leucodystrophy J Neurochem 1966 13 11 1037 1045 5924656
   PubMed Web of Science ®Google Scholar
• Toda K Kobayashi T Goto I Kurokawa T Ogomori K Accumulation of lysosulfatide (sulfogalactosylsphingosine) in tissues of a boy with metachromatic leukodystrophy Biochem Biophys Res Commun 1989 15 159 2 605 611 2539117
   PubMed Web of Science ®Google Scholar
• Toda K Kobayashi T Goto I Lysosulfatide (sulfogalactosylsphingosine) accumulation in tissues from patients with metachromatic leukodystrophy J Neurochem 1990 55 5 1585 1591 1976756
   PubMed Web of Science ®Google Scholar
• Natowicz MR Prence EM Chaturvedi P Newburg DS Urine sulfatides and the diagnosis of metachromatic leukodystrophy Clin Chem 1996 2 2 232 238 8595716
   PubMed Web of Science ®Google Scholar
• Honke K Zhang Y Cheng X Kotani N Taniguchi N Biological roles of sulfoglycolipids and pathophysiology of their deficiency Glycoconj J 2004 21 1–2 59 62 15467400
   PubMed Web of Science ®Google Scholar
• Vitner EB Platt FM Futerman AH Common and uncommon pathogenic cascades in lysosomal storage diseases J Biol Chem 2010 285 27 20423 20427 20430897
   PubMed Web of Science ®Google Scholar
• Webster HD Schwann cell alterations in metachromatic leukodystrophy: preliminary phase and electron microscopic observations J Neuropathol Exp Neurol 1962 21 534 554 13999412
   PubMed Web of Science ®Google Scholar
• Peng L Suzuki K Ultrastructural study of neurons in metachromatic leukodystrophy Clin Neuropathol 1987 6 5 224 230 2826059
   PubMed Web of Science ®Google Scholar
• Berger J Loschl B Bernheimer H Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy Am J Med Genet 1997 69 3 335 340 9096767
   PubMed Web of Science ®Google Scholar
• Polten A Fluharty AL Fluharty CB Kappler J von Figura K Gieselmann V Molecular basis of different forms of metachromatic leukodystrophy N Engl J Med 1991 24 1 18 22 1670590
   PubMed Web of Science ®Google Scholar
• Gieselmann V Krageloh-Mann I Metachromatic leukodystrophy – an update Neuropediatrics 2010 41 1 1 6 20571983
   PubMed Web of Science ®Google Scholar
• Poeppel P Habetha M Marcao A Bussow H Berna L Gieselmann V Missense mutations as a cause of metachromatic leukodystrophy. Degradation of arylsulfatase A in the endoplasmic reticulum FEBS J 2005 272 5 1179 1188 15720392
   PubMed Web of Science ®Google Scholar
• Poeppel P Abouzied MM Volker C Gieselmann V Misfolded endoplasmic reticulum retained subunits cause degradation of wild-type subunits of arylsulfatase A heteromers FEBS J 2010 277 16 3404 3414 20646068
   PubMed Web of Science ®Google Scholar
• Hagberg B Clinical aspects of globoid cell and metachromatic leukodystrophies. Birth Defects Orig Art Ser Feb 1971 7 1 103 112
   Google Scholar
• Hess MW Kirschning E Pfaller K Debbage PL Hohenberg H Klima G 5000-year-old myelin: uniquely intact in molecular configuration and fine structure Curr Biol 1998 8 15 R512 R513 9705943
   PubMed Web of Science ®Google Scholar
• Zoller I Meixner M Hartmann D Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration J Neurosci 2008 24 28 39 9741 9754 18815260
   PubMed Web of Science ®Google Scholar
• O’Brien JS Sampson EL Myelin Membrane: a molecular abnormality Science 1965 150 3703 1613 1614 5866661
   PubMed Web of Science ®Google Scholar
• Tanaka K Nagara H Kobayashi T Goto I The twitcher mouse: accumulation of galactosylsphingosine and pathology of the central nervous system Brain Res 1989 482 2 347 350 2706492
   PubMed Web of Science ®Google Scholar
• Coetzee T Li X Fujita N Molecular cloning, chromosomal mapping, and characterization of the mouse UDP-galactose:ceramide galactosyltransferase gene Genomics 1996 35 1 215 222 8661123
   PubMed Web of Science ®Google Scholar
• Coetzee T Fujita N Dupree J Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability Cell 1996 86 2 209 219 8706126
   PubMed Web of Science ®Google Scholar
• Coetzee T Suzuki K Popko B New perspectives on the function of myelin galactolipids Trends Neurosci 1998 21 3 126 130 9530920
   PubMed Web of Science ®Google Scholar
• Meixner M Jungnickel J Grothe C Gieselmann V Eckhardt M Myelination in the absence of UDP-galactose:ceramide galactosyltransferase and fatty acid 2 -hydroxylase BMC Neurosci 2011 12 22 21366909
   PubMed Web of Science ®Google Scholar
• Potter KA Kern MJ Fullbright G Central nervous system dysfunction in a mouse model of FA2H deficiency Glia 2011 59 7 1009 1021 21491498
   PubMed Web of Science ®Google Scholar
• Imgrund S Hartmann D Farwanah H Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas J Biol Chem 2009 284 48 33549 33560 19801672
   PubMed Web of Science ®Google Scholar
• Pewzner-Jung Y Park H Laviad EL A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways The Journal of biological chemistry 2010 285 14 10902 10910 20110363
   PubMed Web of Science ®Google Scholar
• von Figura K Metachromatic Leukodystrophy Scriver C Beaudet A Arthur L Sly WS Valle D Metabolic and Molecular Basis of Inherited Disease New York McGrw-Hill 2001 3 3696 3724
   Google Scholar
• Hess B Saftig P Hartmann D Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy Proc Natl Acad Sci U S A 1996 93 25 14821 14826 8962139
   PubMed Web of Science ®Google Scholar
• Eckhardt M Hedayati KK Pitsch J Sulfatide storage in neurons causes hyperexcitability and axonal degeneration in a mouse model of metachromatic leukodystrophy J Neurosci 2007 27 34 9009 9021 17715338
   PubMed Web of Science ®Google Scholar
• Walkley SU Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome Acta Paediatr Suppl 2007 96 455 26 32 17391436
   PubMedGoogle Scholar
• Walkley SU Pathogenic cascades in lysosomal disease-Why so complex? J Inherit Metab Dis 2009 32 2 181 189 19130290
   PubMed Web of Science ®Google Scholar
• Paez PM Fulton D Colwell CS Campagnoni AT Voltage-operated Ca(2+) and Na(+) channels in the oligodendrocyte lineage J Neurosci Res 2009 87 15 3259 3266 19021296
   PubMed Web of Science ®Google Scholar
• Paez PM Fulton DJ Spreuer V Golli myelin basic proteins regulate oligodendroglial progenitor cell migration through voltagegated Ca2+ influx J Neurosci 2009 29 20 6663 6676 19458236
   PubMed Web of Science ®Google Scholar
• Pelled D Trajkovic-Bodennec S Lloyd-Evans E Sidransky E Schiffmann R Futerman AH Enhanced calcium release in the acute neuronopathic form of Gaucher disease Neurobiol Dis 2005 18 1 83 88 15649698
   PubMed Web of Science ®Google Scholar
• Ausseil J Desmaris N Bigou S Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice PLoS One 2008 3 5 e2296 18509511
   PubMed Web of Science ®Google Scholar
• Shimada Y Kobayashi H Kawagoe S Endoplasmic reticulum stress induces autophagy through activation of p38 MAPK in fibroblasts from Pompe disease patients carrying c.546G>T mutation Mol Genet Metab 2011 104 4 566 573 21982629
   PubMed Web of Science ®Google Scholar
• Warr MR Binnewies M Flach J FOXO3A directs a protective autophagy program in haematopoietic stem cells Nature 2013 494 7437 323 327 23389440
   PubMed Web of Science ®Google Scholar
• Nishiyama Y Shimada Y Yokoi T Akt inactivation induces endoplasmic reticulum stress-independent autophagy in fibroblasts from patients with Pompe disease Mol Genet Metab 2012 107 3 490 495 23041259
   PubMed Web of Science ®Google Scholar
• Lloyd-Evans E Morgan AJ He X Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium Nat Med 2008 14 11 1247 1255 18953351
   PubMed Web of Science ®Google Scholar
• Chen CS Patterson MC Wheatley CL O’Brien JF Pagano RE Broad screening test for sphingolipid-storage diseases Lancet 1999 354 9182 901 905 10489949
   PubMed Web of Science ®Google Scholar
• Mukherjee S Soe TT Maxfield FR Endocytic sorting of lipid analogues differing solely in the chemistry of their hydrophobic tails J Cell Biol 1999 144 6 1271 1284 10087269
   PubMed Web of Science ®Google Scholar
• Settembre C Fraldi A Jahreiss L A block of autophagy in lysosomal storage disorders Hum Mol Genet 2008 17 1 119 129 17913701
   PubMed Web of Science ®Google Scholar
• Settembre C Arteaga-Solis E McKee MD Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification Genes Dev 2008 22 19 2645 2650 18832069
   PubMed Web of Science ®Google Scholar
• Settembre C Annunziata I Spampanato C Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency Proc Natl Acad Sci U S A 2007 104 11 4506 4511 17360554
   PubMed Web of Science ®Google Scholar
• Dierks T Schmidt B Borissenko LV Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme Cell 2003 113 4 435 444 12757705
   PubMed Web of Science ®Google Scholar
• Lo EH Degeneration and repair in central nervous system disease Nat Med 2010 16 11 1205 1209 21052074
   PubMed Web of Science ®Google Scholar
• Pardridge WM The blood-brain barrier: bottleneck in brain drug development NeuroRx 2005 2 1 3 14 15717053
   PubMedGoogle Scholar
• Ghose AK Viswanadhan VN Wendoloski JJ A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases J Comb Chem 1999 1 1 55 68 10746014
   PubMedGoogle Scholar
• Priller J Flugel A Wehner T Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment Nat Med 2001 7 12 1356 1361 11726978
   PubMed Web of Science ®Google Scholar
• Mehl E Jatzkewitz H A cerebrosidesulfatase from swine kidney Hoppe Seylers Z Physiol Chem 1964 339 1 260 276 5829234
   PubMedGoogle Scholar
• Saravanan K Schaeren-Wiemers N Klein D Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder Neurobiol Dis 2004 16 2 396 406 15193296
   PubMed Web of Science ®Google Scholar
• Wittke D Hartmann D Gieselmann V Lullmann-Rauch R Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution Acta Neuropathol 2004 108 4 261 271 15322834
   PubMed Web of Science ®Google Scholar
• Krivit W Shapiro E Kennedy W Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation N Engl J Med 1990 322 1 28 32 1967188
   PubMed Web of Science ®Google Scholar
• Martin HR Poe MD Provenzale JM Kurtzberg J Mendizabal A Escolar ML Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy Biol Blood Marrow Transplant 2013 19 4 616 624 23348427
   PubMed Web of Science ®Google Scholar
• Malm G Ringden O Winiarski J Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation Bone Marrow Transplant 1996 17 6 1003 1008 8807106
   PubMed Web of Science ®Google Scholar
• Nagai T Kaneko T Shichijou H Karato T Maruyama A Tsuchiya Y Bone marrow transplantation for late infantile metachromatic leukodystrophy: pathogenic investigation for graft rejection Acta Paediatr Jpn 1993 35 5 404 408 8256624
   PubMedGoogle Scholar
• Navarro C Dominguez C Fernandez JM Fachal C Alvarez M Case report: four-year follow-up of bone-marrow transplantation in late juvenile metachromatic leukodystrophy J Inherit Metab Dis 1995 18 2 157 158 7564234
   PubMed Web of Science ®Google Scholar
• Solders G Celsing G Hagenfeldt L Ljungman P Isberg B Ringden O Improved peripheral nerve conduction, EEG and verbal IQ after bone marrow transplantation for adult metachromatic leukodystrophy Bone Marrow Transplant 1998 22 11 1119 1122 9877277
   PubMed Web of Science ®Google Scholar
• Walkley SU Wurzelmann S Siegel DA Ectopic axon hillockassociated neurite growth is maintained in metabolically reversed swainsonine-induced neuronal storage disease Brain Res 1987 410 1 89 96 3107757
   PubMed Web of Science ®Google Scholar
• Matzner U Lullmann-Rauch R Stroobants S Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy Mol Ther 2009 17 4 600 606 19174759
   PubMed Web of Science ®Google Scholar
• Matthes F Stroobants S Gerlach D Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age Hum Mol Genet 2012 21 11 2599 2609 22388935
   PubMed Web of Science ®Google Scholar
• Martino S Consiglio A Cavalieri C Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement therapy J Biotechnol 2005 117 3 243 251 15862354
   PubMed Web of Science ®Google Scholar
• Asheuer M Pflumio F Benhamida S Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein Proc Nat Acad Sci U S A 2004 101 10 3557 3562
   PubMed Web of Science ®Google Scholar
• Saftig P Klumperman J Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function Nat Rev Mol Cell Biol 2009 10 9 623 635 19672277
   PubMed Web of Science ®Google Scholar
• Bredius RG Laan LA Lankester AC Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression Bone Marrow Transplant 2007 39 5 309 310 17237829
   PubMed Web of Science ®Google Scholar
• Krivit W Peters C Shapiro EG Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III Curr Opin Neurol 1999 12 2 167 176 10226749
   PubMedGoogle Scholar
• Malatack JJ Consolini DM Bayever E The status of hematopoietic stem cell transplantation in lysosomal storage disease Pediatr Neurol 2003 29 5 391 403 14684234
   PubMed Web of Science ®Google Scholar
• Peters C Steward CG Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines Bone Marrow Transplant 2003 31 4 229 239 12621457
   PubMed Web of Science ®Google Scholar
• Biffi A Lucchini G Rovelli A Sessa M Metachromatic leukodystrophy: an overview of current and prospective treatments Bone Marrow Transplant 2008 42 Suppl 2 S2 S6 18978739
   PubMed Web of Science ®Google Scholar
• Orchard PJ Tolar J Transplant outcomes in leukodystrophies Semin Hematol 2010 47 1 70 78 20109614
   PubMed Web of Science ®Google Scholar
• Batzios S P Zafeiriou DI Developing treatment options for metachromatic leukodystrophy Mol Genet Metab 2012 105 1 56 63 22078456
   PubMed Web of Science ®Google Scholar
• Matzner U Gieselmann V Gene therapy of metachromatic leukodystrophy Expert Opin Biol Ther 2005 5 1 55 65 15709909
   PubMed Web of Science ®Google Scholar
• Biffi A De Palma M Quattrini A Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells J Clin Invest 2004 113 8 1118 1129 15085191
   PubMed Web of Science ®Google Scholar
• Biffi A Capotondo A Fasano S Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice J Clin Invest 2006 116 11 3070 3082 17080200
   PubMed Web of Science ®Google Scholar
• Matzner U Hartmann D Lullmann-Rauch R Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations Gene Ther 2002 9 1 53 63 11850723
   PubMed Web of Science ®Google Scholar
• Capotondo A Cesani M Pepe S Safety of arylsulfatase A overexpression for gene therapy of metachromatic leukodystrophy Hum Gene Ther 2007 18 9 821 836 17845130
   PubMed Web of Science ®Google Scholar
• Consiglio A Martino S Dolcetta D Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts J Neurol Sci 2007 255 1–2 7 16 17341424
   PubMed Web of Science ®Google Scholar
• Lagranha VL Baldo G de Carvalho TG In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells Metab Brain Dis 2008 23 4 469 484 18797988
   PubMed Web of Science ®Google Scholar
• Givogri MI Galbiati F Fasano S Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy J Neurosci 2006 26 12 3109 3119 16554462
   PubMed Web of Science ®Google Scholar
• Kawabata K Migita M Mochizuki H Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres Brain Res 2006 1094 1 13 23 16729983
   PubMed Web of Science ®Google Scholar
• Givogri MI Bottai D Zhu HL Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction Dev Neurosci 2008 30 5 340 357 18667806
   PubMed Web of Science ®Google Scholar
• Klein D Schmandt T Muth-Kohne E Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy Gene Ther 2006 13 24 1686 1695 16871228
   PubMed Web of Science ®Google Scholar
• Zervas M Somers KL Thrall MA Walkley SU Critical role for glycosphingolipids in Niemann-Pick disease type C Curr Biol 200 11 16 1283 1287 11525744
   PubMed Web of Science ®Google Scholar
• Platt FM Neises GR Dwek RA Butters TD N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis J Biol Chem 1994 269 11 8362 8365 8132559
   PubMed Web of Science ®Google Scholar
• Grabowski GA Osiecki-Newman K Dinur T Human acid betaglucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes J Biol Chem 1986 261 18 8263 8269 3087971
   PubMed Web of Science ®Google Scholar
• Adachi M Volk BW Gaucher disease in mice induced by conduritol-B-epoxide: morphologic features Arch Pathol Lab Med 1977 101 5 255 259 576797
   PubMed Web of Science ®Google Scholar
• Platt FM Jeyakumar M Substrate reduction therapy Acta Paediatr Suppl 2008 97 457 88 93 18339196
   PubMedGoogle Scholar
• Platt FM Neises GR Reinkensmeier G Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin Science 1997 276 5311 428 431 9103204
   PubMed Web of Science ®Google Scholar
• Maegawa GH van Giersbergen PL Yang S Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis Mol Genet Metab 2009 97 4 284 291 19447653
   PubMed Web of Science ®Google Scholar
• Maegawa GH Banwell BL Blaser S Substrate reduction therapy in juvenile GM2 gangliosidosis Mol Genet Metab 2009 98 1–2 215 224 19595619
   PubMed Web of Science ®Google Scholar
• Patterson MC Vecchio D Prady H Abel L Wraith JE Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study Lancet Neurol 2007 6 9 765 772 17689147
   PubMed Web of Science ®Google Scholar
• Sundaram KS Lev M Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain J Lipid Res 11 1988 29 11 1475 1479 3241123
   PubMed Web of Science ®Google Scholar
• Assadi M Wang DJ Anderson K Carran M Bilaniuk L Leone P Vitamin k antagonist warfarin for palliative treatment of metachromatic leukodystrophy, a compassionate study of four subjects J Cent Nerv Syst Dis 2012 4 73 79 23650469
   PubMedGoogle Scholar
• Bernier V Lagace M Bichet DG Bouvier M Pharmacological chaperones: potential treatment for conformational diseases Trends Endocrinol Metab 2004 15 5 222 228 15223052
   PubMed Web of Science ®Google Scholar
• Leinekugel P Michel S Conzelmann E Sandhoff K Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease Hum Genet 1992 88 5 513 523 1348043
   PubMed Web of Science ®Google Scholar
• Wiseman RL Powers ET Buxbaum JN Kelly JW Balch WE An adaptable standard for protein export from the endoplasmic reticulum Cell 2007 131 4 809 821 18022373
   PubMed Web of Science ®Google Scholar
• Maegawa GH Tropak M Buttner J Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis J Biol Chem 2007 282 12 9150 9161 17237499
   PubMed Web of Science ®Google Scholar
• Maegawa GH Tropak MB Buttner JD Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease J Biol Chem 2009 284 35 23502 23516 19578116
   PubMed Web of Science ®Google Scholar
• Beck M Emerging drugs for lysosomal storage diseases Expert Opin Emerg Drugs 2010 15 3 495 507 20557271
   PubMed Web of Science ®Google Scholar
• Fan JQ A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity Biol Chem 2008 389 1 1 11 18095864
   PubMed Web of Science ®Google Scholar
• Balch WE Morimoto RI Dillin A Kelly JW Adapting proteostasis for disease intervention Science 2008 319 5865 916 919 18276881
   PubMed Web of Science ®Google Scholar
• Harbut MB Patel BA Yeung BK Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic design Proc Natl Acad Sci U S A 2012 109 52 21486 21491 23236186
   PubMed Web of Science ®Google Scholar
• Elfrink HL Zwart R Baas F Scheper W Inhibition of endoplasmic reticulum associated degradation reduces endoplasmic reticulum stress and alters lysosomal morphology and distribution Mol Cells 2013 35 4 291 297 23515578
   PubMed Web of Science ®Google Scholar
• Wang F Segatori L Remodeling the proteostasis network to rescue glucocerebrosidase variants by inhibiting ER-associated degradation and enhancing ER folding PLoS One 2013 8 4 e61418 23620750
   PubMed Web of Science ®Google Scholar
• Mu TW Ong DS Wang YJ Chemical and biological approaches synergize to ameliorate protein-folding diseases Cell 2008 134 5 769 781 18775310
   PubMed Web of Science ®Google Scholar
• Mu TW Fowler DM Kelly JW Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis PLoS Biol 2008 6 2 e26 18254660
   PubMed Web of Science ®Google Scholar
• Yang C Rahimpour S Lu J Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones Proc Natl Acad Sci U S A 2013 110 3 966 971 23277556
   PubMed Web of Science ®Google Scholar
• An WF Tolliday N Cell-based assays for high-throughput screening Mol Biotechnol 2010 45 2 180 186 20151227
   PubMed Web of Science ®Google Scholar
• Hampton SL Kinnaird AI Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery Cell Biol Toxicol 2010 26 1 43 55 19904619
   PubMed Web of Science ®Google Scholar
• Geng H Whiteley G Ribbens J Novel patient cell-based HTS assay for identification of small molecules for a lysosomal storage disease PLoS One 2011 6 12 e29504 22216298
   PubMed Web of Science ®Google Scholar
• Ribbens J Whiteley G Furuya H A high-throughput screening assay using Krabbe disease patient cells Anal Biochem 2012 434 1 15 25 23138179
   PubMed Web of Science ®Google Scholar
• Pelled D Lloyd-Evans E Riebeling C Jeyakumar M Platt FM Futerman AH Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin J Biol Chem 2003 278 32 29496 29501 12756243
   PubMed Web of Science ®Google Scholar
• Jeyakumar M Smith DA Williams IM NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin Ann Neurol 2004 56 5 642 649 15505823
   PubMed Web of Science ®Google Scholar
• Smith D Wallom K-L Williams IM Jeyakumar M Platt FM Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1 Neurobiol Dis 2009 36 2 242 251 19632328
   PubMed Web of Science ®Google Scholar
• Inglese J Auld DS Jadhav A Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries Proc Natl Acad Sci U S A 2006 103 31 11473 11478 16864780
   PubMed Web of Science ®Google Scholar
• National Center for Research Resources (NCRR) Stem cell transplantation (SCT) for genetic diseases Available from http://clinicaltrials.gov/ct2/show/NCT00004378?term=NCT00004378&rank=1. NLM identifier NCT00004378Accessed July 8, 2013
   Google Scholar
• Masonic Cancer Center, University of Minnesota Stem cell transplant for inborn errors of metabolism Available from http://clinicaltrials.gov/ct2/show/NCT00176904?term=NCT00176904&rank=1. /NLM identifier NCT00176904Accessed July 8, 2013
   Google Scholar
• Shire Human Genetic Therapies, Inc Long-term Metazym treatment of patients with late infantile metachromatic leukodystrophy (MLD) Available from http://clinicaltrials.gov/ct2/show/NCT00633139?term=NCT00633139&rank=1. NLM identifier NCT00633139Accessed July 8, 2013
   Google Scholar
• Shire Human Genetic Therapies, Inc Multicenter study of HGT-1110 enzyme replacement therapy administered intrathecally in children with metachromatic leukodystrophy (IDEAMLD) Available from http://clinicaltrials.gov/ct2/show/NCT01510028?term=NCT01510028&rank=1. NLM identifier NCT0150039Accessed July 8, 2013
   Google Scholar
• Assistance Publique – Hôpitaux de Paris Efficacy of Metazym for the treatment of metachromatic leukodystrophy treated with hematopoietic stem cell transplantation (Azylis) Available at http://clinicaltrials.gov/ct2/show/NCT01303146?term=NCT01303146&rank=1. NLM identifier NCT 01303146Accessed July 8, 2013
   Google Scholar
• Shire Human Genetic Therapies, Inc Open-label extension study of recombinant human arylsulfatase A (HGT-1111) in late infantile MLD Available at http://clinicaltrials.gov/ct2/show/NCT00681811?term=NCT00681811&rank=1. NLM identifier NCT 00681811Accessed July 22, 2013
   Google Scholar
• Shire Human Genetic Therapies, Inc Metazym for the treatment of patients with late infantile metachromatic leukodystrophy Available from http://clinicaltrials.gov/ct2/show/NCT00418561?term=NCT00418561&rank=1. NLM identifier NCT00418561Accessed July 8, 2013
   Google Scholar
• IRCCS San Raffaele Gene therapy for metachromatic leukodystrophy (TIGET-MLD Available from http://clinicaltrials.gov/ct2/show/NCT01560182?term=NCT01560182&rank=1. NLM identifier NCT01560182Accessed July 8, 2013
   Google Scholar
• Institut National de la Santé Et de la Recherche Médicale, France Intracerebral gene therapy for children with early onset forms of metachromatic leukodystrophy (TG-MLD) Available from http://clinicaltrials.gov/ct2/show/NCT01801709?term=NCT01801709&rank=1. NLM identifier NCT 01801709Accessed July 8, 2013
   Google Scholar
• The Cooper Health System Effect of warfarin in the treatment of metachromatic leukodystrophy Available at http://clinicaltrials.gov/ct2/show/NCT00683189?term=NCT00683189&rank=1. NLM identifer NCT00683189Accessed July 8, 2013
   Google Scholar